ARMISTICE CAPITAL, LLC - Q4 2016 holdings

$423 Million is the total value of ARMISTICE CAPITAL, LLC's 48 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .

 Value Shares↓ Weighting
NewVERIFONE SYS INCcall$12,411,000700,000
+100.0%
2.94%
NVLNF NewNOVELION THERAPEUTICS INC$11,956,0001,420,000
+100.0%
2.83%
HBI NewHANESBRANDS INC$11,562,000536,000
+100.0%
2.74%
HZNP NewHORIZON PHARMA PLC$10,517,000650,000
+100.0%
2.49%
TPX NewTEMPUR SEALY INTL INC$9,559,000140,000
+100.0%
2.26%
CPB NewCAMPBELL SOUP CO$9,554,000158,000
+100.0%
2.26%
ADMS NewADAMAS PHARMACEUTICALS INC$9,058,000536,000
+100.0%
2.14%
URBN NewURBAN OUTFITTERS INC$8,544,000300,000
+100.0%
2.02%
AEO NewAMERICAN EAGLE OUTFITTERS NE$7,949,000524,000
+100.0%
1.88%
AET NewAETNA INC NEW$7,937,00064,000
+100.0%
1.88%
SHPG NewSHIRE PLCsponsored adr$7,837,00046,000
+100.0%
1.85%
TSCO NewTRACTOR SUPPLY CO$7,581,000100,000
+100.0%
1.79%
SIG NewSIGNET JEWELERS LIMITED$5,844,00062,000
+100.0%
1.38%
JCPNQ NewPENNEY J C INC$5,817,000700,000
+100.0%
1.38%
SAM NewBOSTON BEER INCcl a$5,775,00034,000
+100.0%
1.37%
PII NewPOLARIS INDS INC$5,767,00070,000
+100.0%
1.36%
LOCO NewEL POLLO LOCO HLDGS INC$4,723,000384,000
+100.0%
1.12%
DLTR NewDOLLAR TREE INC$3,859,00050,000
+100.0%
0.91%
BJRI NewBJS RESTAURANTS INC$3,458,00088,000
+100.0%
0.82%
NewDUNKIN BRANDS GROUP INCcall$3,146,00060,000
+100.0%
0.74%
BLUE NewBLUEBIRD BIO INC$2,468,00040,000
+100.0%
0.58%
DFRG NewDEL FRISCOS RESTAURANT GROUP$1,904,000112,000
+100.0%
0.45%
ROKA NewROKA BIOSCIENCE INC$1,001,000236,000
+100.0%
0.24%
BLPH NewBELLEROPHON THERAPEUTICS INC$520,0001,000,000
+100.0%
0.12%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings